FDA Inspection 1141200 — CMIC CMO USA Corporation
The FDA completed an inspection of CMIC CMO USA Corporation on May 4, 2021 in Cranbury, NJ. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- May 4, 2021
- Fiscal Year
- 2021
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Cranbury, NJ (United States)